
| ASSET | DATE | % RETURN |
|---|---|---|
Rezolve AI Limited Ordinary Shares (RZLV) | 4/21/2025 - 4/30/2025 | 69.85% |
Highest Performances (MAAS) | 4/21/2025 - 4/30/2025 | 66.18% |
Forge Global (FRGE) | 4/21/2025 - 4/30/2025 | 64.66% |
Regenxbio (RGNX) | 4/21/2025 - 4/30/2025 | 63.16% |
DeFi Development (DFDV) | 4/21/2025 - 4/30/2025 | 61.55% |
Taysha Gene Therapies (TSHA) | 4/21/2025 - 4/30/2025 | 57.72% |
Healthcare Services (HCSG) | 4/21/2025 - 4/30/2025 | 50.37% |
Wolfspeed (WOLF) | 4/21/2025 - 4/30/2025 | 49.79% |
Wheels Up Experience (UP) | 4/21/2025 - 4/30/2025 | 49.33% |
Kodiak Sciences (KOD) | 4/21/2025 - 4/30/2025 | 47.3% |
ECARX Holdings Inc Class A Ordinary shares (ECX) | 4/21/2025 - 4/30/2025 | 47.28% |
Lexeo Therapeutics, Inc Common Stock (LXEO) | 4/21/2025 - 4/30/2025 | 46.1% |
QuantaSing Group Limited American Depositary Shares (QSG) | 4/21/2025 - 4/30/2025 | 45.18% |
American Battery Technology Company Common Stock (ABAT) | 4/21/2025 - 4/30/2025 | 43.7% |
Lexicon Pharmaceuticals (LXRX) | 4/21/2025 - 4/30/2025 | 43.63% |
Design Therapeutics (DSGN) | 4/21/2025 - 4/30/2025 | 42.94% |
Leggett & Platt (LEG) | 4/21/2025 - 4/30/2025 | 41.89% |
Babcock & Wilcox Enterprises (BW) | 4/21/2025 - 4/30/2025 | 40.98% |
Larimar Therapeutics (LRMR) | 4/21/2025 - 4/30/2025 | 40.96% |
Kopin (KOPN) | 4/21/2025 - 4/30/2025 | 40.44% |
Prime Medicine, Inc Common Stock (PRME) | 4/21/2025 - 4/30/2025 | 39.52% |
MBX Biosciences, Inc Common Stock (MBX) | 4/21/2025 - 4/30/2025 | 38.57% |
Rezolute (RZLT) | 4/21/2025 - 4/30/2025 | 36.23% |
ThredUp (TDUP) | 4/21/2025 - 4/30/2025 | 34.83% |
Evolv Technologies (EVLV) | 4/21/2025 - 4/30/2025 | 34.25% |